Adaptive Biotechnologies (ADPT) Inventory Average (2019 - 2026)

Adaptive Biotechnologies (ADPT) has 8 years of Inventory Average data on file, last reported at $10.5 million in Q1 2026.

• Quarterly Inventory Average rose 22.79% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 22.79% YoY) and the FY2025 annual result came in at $9.1 million, down 20.22% from the prior year.
• Inventory Average advanced to $10.5 million in Q1 2026 per ADPT's latest filing, from $9.9 million in the prior quarter.
• The five-year high for Inventory Average was $20.1 million in Q1 2022, with the low at $8.5 million in Q2 2025.
• Average Inventory Average over 5 years is $14.3 million, with a median of $13.9 million recorded in 2024.
• Year-over-year, Inventory Average gained 27.89% in 2022 and slumped 39.91% in 2024.
• Adaptive Biotechnologies' Inventory Average stood at $15.9 million in 2022, then advanced by 6.73% to $17.0 million in 2023, then tumbled by 39.91% to $10.2 million in 2024, then dropped by 3.15% to $9.9 million in 2025, then increased by 6.44% to $10.5 million in 2026.
• Business Quant data shows ADPT's Inventory Average at $10.5 million in Q1 2026, $9.9 million in Q4 2025, and $9.2 million in Q3 2025.